A wide range of different agents are capable of inducing the onset of HL-60 differentiation along the myeloid lineage. The diversity of these agents has made the analysis of the molecular mechanisms involved in the regulation of the onset and progress of terminal differentiation in these cells difficult. We have adapted the standard soft-agar cloning procedure to enable the single-step selection of clonal populations of spontaneously arising differentiation resistant HL-60 variants. This simple procedure which obviates the need for mutagenesis, long-term exposure to inducing agents or complex manipulations, optimises the chance of obtaining variants with a single lesion blocking the onset of differentiation. The analysis of two variants, HL...
Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoi...
<div><p>Emergent resistance can be progressive and driven by global signaling aberrations. All-<i>tr...
Acute myeloid leukemia (AML) is characterized by a differentiation block in the myeloid lineages of ...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
HL60 is a human promyelocytic, leukaemic cell line. The cells are bipotent in culture; treatment wit...
Differentiation induction therapy aims to "reform, rather than retaliate" like conventional chemothe...
HL60 is a human promyelocytic, leukaemic cell line. The cells are bipotent in culture; treatment wit...
HL60 myeloid leukemia cells are extensively used as a differentiation model. We investigated a varia...
The expression of the X-CGD gene, which encodes the heavy-chain subunit of the phagocyte cytochrome ...
Differentiation therapy in the treatment of leukemia is often hampered by limitations on using certa...
Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoi...
Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoi...
<div><p>Emergent resistance can be progressive and driven by global signaling aberrations. All-<i>tr...
Acute myeloid leukemia (AML) is characterized by a differentiation block in the myeloid lineages of ...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
A wide range of different agents are capable of inducing the onset of HL-60 differentiation along th...
HL60 is a human promyelocytic, leukaemic cell line. The cells are bipotent in culture; treatment wit...
Differentiation induction therapy aims to "reform, rather than retaliate" like conventional chemothe...
HL60 is a human promyelocytic, leukaemic cell line. The cells are bipotent in culture; treatment wit...
HL60 myeloid leukemia cells are extensively used as a differentiation model. We investigated a varia...
The expression of the X-CGD gene, which encodes the heavy-chain subunit of the phagocyte cytochrome ...
Differentiation therapy in the treatment of leukemia is often hampered by limitations on using certa...
Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoi...
Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoi...
<div><p>Emergent resistance can be progressive and driven by global signaling aberrations. All-<i>tr...
Acute myeloid leukemia (AML) is characterized by a differentiation block in the myeloid lineages of ...